🇵🇱 POLSKIE LABORATORIUM ANTYDOPINGOWE PL
Other
POLSKIE LABORATORIUM ANTYDOPINGOWE is a laboratory accredited by PCA under number AB 108 (Warszawa, Poland). Its accreditation scope covers 14 test methods in the following areas: Other. Test objects include: Human urine E, Human blood*. Most frequently used techniques: GC/MS/MS, GC/MS, GC/C/IRMS.
At a glance
- Accreditation number: PCA AB 108
- Methods in scope: 14
- Types of test objects: 2
- Techniques used: 8
- City: Warszawa, Poland
- Accreditation number
- AB 108
- Accreditation body
- PCA
- Address
- ul. Księcia Ziemowita 53 bud.4, 03-885 Warszawa
- City
- Warszawa, Poland
What this laboratory tests (2)
- Human urine E — 12 methods
- Human blood* — 2 methods
Analytical techniques used (8)
- GC/MS/MS — 3 methods
- GC/MS — 2 methods
- GC/C/IRMS — 1 method
- GC/C/IRMS/MS — 1 method
- GC/MS/MS method — 1 method
- GC/MS/MS method* — 1 method
- GC/MS/MS* — 1 method
- refractometric method — 1 method
Certificate information
- Issue date
- 05.03.2026
- Issue no.
- 25
Accreditation scope — test methods (14)
| No. | Test object | Methodology / Parameters | Technique | Reference document | |
|---|---|---|---|---|---|
| Test methods | |||||
| 1 | Human urine E | Presence of free stimulants and certain narcotic drugs | GC/MS | Test procedure 14 (SOP 14) _ test procedure 15 (SOP 15) _ | |
| 2 | Human urine E | Differentiation of exogenous and endogenous anabolic-androgenic steroids | GC/C/IRMS | Test procedure 23 (SOP 23) | |
| 3 | Human urine E | Differentiation of exogenous and endogenous anabolic-androgenic steroids | GC/C/IRMS/MS | Test procedure 23 (SOP 23) | |
| 4 | Human urine E | Presence of doping substances | GC/MS/MS | Test procedure 35 (SOP 35) _ test procedure 14 (SOP 14) _ test procedure 15 (SOP 15) | |
| 5 | Human urine E | Determination of specific gravity | refractometric method | Test procedure 43 (SOP 43) | |
| 6 | Human urine E | Morphine concentration | GC/MS/MS method | Test procedure 3a (SOP 3a) _ | |
| 7 | Human urine E | Presence of 19-norandrosterone | GC/MS/MS | Test procedure 7a (SOP 7a) | |
| 8 | Human urine E | Salbutamol concentration | Test procedure 9a (SOP 9a) | ||
| 9 | Human urine E | GC/MS | |||
| 10 | Human urine E | GC/MS/MS | |||
| 11 | Human urine E | Tetrahydrocannabinol concentration Tetrahydrocannabinol concentration |
GC/MS | Test procedure 10a (SOP 10a) | |
| 12 | Human urine E | Tetrahydrocannabinol concentration Tetrahydrocannabinol concentration |
GC/MS/MS | Test procedure 10a (SOP 10a) | |
| 13 | Human blood* | Presence of tetrahydrocannabinols* | GC/MS/MS* | Test procedure 25 (SOP 25* _ | Test procedure 26 (SOP 26)* _ | |
| 14 | Human blood* | Presence of 4-hydroxybutanoic acid* | GC/MS/MS method* | Test procedure 42 (SOP 42)* | Test procedure 26 (SOP 26)* | |
Reference standards (12)
Test procedure 10a (SOP 10a)
Test procedure 14 (SOP 14) _ test procedure 15 (SOP 15) _
Test procedure 23 (SOP 23)
Test procedure 25 (SOP 25* _
Test procedure 26 (SOP 26)*
Test procedure 26 (SOP 26)* _
Test procedure 35 (SOP 35) _ test procedure 14 (SOP 14) _ test procedure 15 (SOP 15)
Test procedure 3a (SOP 3a) _
Test procedure 42 (SOP 42)*
Test procedure 43 (SOP 43)
Test procedure 7a (SOP 7a)
Test procedure 9a (SOP 9a)